Association Between High Sensitivity Troponin Levels Following Pediatric Orthotopic Heart Transplantation and Intensive Care Unit Resource Utilization

Overview

Journal Pediatr Cardiol

Specialties Cardiology & Vascular Diseases
Pediatrics

Date 2024 Feb 29

PMID 38424311

Authors

Adam M Butensky

Shyam Desai

Michael Dilorenzo

Irene D Lytrivi

Benjamin S Mantell

Yun Zhang

Tarif A Choudhury

Affiliations

Soon will be listed here.

Abstract

The utility of troponin levels, including high sensitivity troponin T (hs-TnT), after orthotopic heart transplant (OHT) is controversial. Conflicting data exist regarding its use as a marker of acute rejection. Few studies have examined possible associations of hs-TnT levels immediately after OHT with metrics of intensive care unit (ICU) resource utilization or risk of acute rejection. We performed a retrospective cohort chart review including all OHT recipients < 20 years of age at our center between June 2019 and December 2022. Patients were divided into two groups based on supra- or sub-median initial hs-TnT levels (median 3462.5 ng/L). Primary outcome was days requiring ICU-level care, secondary outcomes included days intubated, days requiring positive pressure ventilation (PPV), days on inotropic medications, actual ICU length of stay, Vasoactive Inotrope Scores (VIS) on postoperative days (POD) 0 through 7, and acute rejection at 30 days and one year after OHT. Patients with higher hs-TnT required ICU level care for longer [13.5 (10-17.5) vs. 9.5 (8-12) days, p = 0.01] and spent more days intubated [6 (4-7) vs. 3 (3-5) days, p < 0.001], on PPV [9 (6-15) vs. 6 (5-8.5) days, p = 0.02], and on inotropes [11 (9-14) vs. 8 (7-11) days, p = 0.025]. VIS was only different between groups on POD7 [5 (3-7) vs. 3 (0-5), p = 0.04]. There was no difference in rejection between the groups. Higher hs-TnT immediately following pediatric OHT may predict higher ICU resource utilization, despite no difference in VIS, although it does not predict acute rejection in the first year after OHT.

References

Rossano J, Cherikh W, Chambers D, Goldfarb S, Hayes Jr D, Khush K . The International Thoracic Organ Transplant Registry of the International Society for Heart and Lung Transplantation: Twenty-first pediatric heart transplantation report-2018; Focus theme: Multiorgan Transplantation. J Heart Lung Transplant. 2018; 37(10):1184-1195. DOI: 10.1016/j.healun.2018.07.018. View

McCulloch M, Zuckerman W, Moller T, Knecht K, Lin K, Beasley G . Effects of donor cause of death, ischemia time, inotrope exposure, troponin values, cardiopulmonary resuscitation, electrocardiographic and echocardiographic data on recipient outcomes: A review of the literature. Pediatr Transplant. 2020; 24(3):e13676. DOI: 10.1111/petr.13676. View

Tallaj J, Pamboukian S, George J, Kirklin J, Brown R, McGiffin D . Have risk factors for mortality after heart transplantation changed over time? Insights from 19 years of Cardiac Transplant Research Database study. J Heart Lung Transplant. 2014; 33(12):1304-11. DOI: 10.1016/j.healun.2014.08.014. View

Hong K, Iribarne A, Worku B, Takayama H, Gelijns A, Naka Y . Who is the high-risk recipient? Predicting mortality after heart transplant using pretransplant donor and recipient risk factors. Ann Thorac Surg. 2011; 92(2):520-7. PMC: 4243707. DOI: 10.1016/j.athoracsur.2011.02.086. View

Kanaan U, Chiang V . Cardiac troponins in pediatrics. Pediatr Emerg Care. 2004; 20(5):323-9. DOI: 10.1097/01.pec.0000125664.35690.51. View

Jaffe A, Ravkilde J, Roberts R, Naslund U, Apple F, Galvani M . It's time for a change to a troponin standard. Circulation. 2000; 102(11):1216-20. DOI: 10.1161/01.cir.102.11.1216. View

Alpert J, Thygesen K, Antman E, Bassand J . Myocardial infarction redefined--a consensus document of The Joint European Society of Cardiology/American College of Cardiology Committee for the redefinition of myocardial infarction. J Am Coll Cardiol. 2000; 36(3):959-69. DOI: 10.1016/s0735-1097(00)00804-4. View

Garg P, Morris P, Fazlanie A, Vijayan S, Dancso B, Dastidar A . Cardiac biomarkers of acute coronary syndrome: from history to high-sensitivity cardiac troponin. Intern Emerg Med. 2017; 12(2):147-155. PMC: 5329082. DOI: 10.1007/s11739-017-1612-1. View

Clerico A, Aimo A, Cantinotti M . High-sensitivity cardiac troponins in pediatric population. Clin Chem Lab Med. 2021; 60(1):18-32. DOI: 10.1515/cclm-2021-0976. View

10.

Wang A, Homme J, Qureshi M, Sandoval Y, Jaffe A . High-Sensitivity Troponin T Testing for Pediatric Patients in the Emergency Department. Pediatr Cardiol. 2021; 43(2):350-359. DOI: 10.1007/s00246-021-02726-7. View

11.

Boronski B, Piotrowski A, Pagowska-Klimek I . Value of troponin T measurements for prediction of postoperative course and length of ICU stay of children after surgical correction of congenital heart disease. Anaesthesiol Intensive Ther. 2022; 54(2):114-119. PMC: 10156510. DOI: 10.5114/ait.2022.114488. View

12.

Mori Y, Nakashima Y, Kaneko S, Inoue N, Murakami T . Risk Factors for Cardiac Adverse Events in Infants and Children with Complex Heart Disease Scheduled for Bi-ventricular Repair: Prognostic Value of Pre-operative B-Type Natriuretic Peptide and High-Sensitivity Troponin T. Pediatr Cardiol. 2020; 41(8):1756-1765. DOI: 10.1007/s00246-020-02437-5. View

13.

Immer F, Stocker F, Seiler A, Pfammatter J, Bachmann D, Printzen G . Troponin-I for prediction of early postoperative course after pediatric cardiac surgery. J Am Coll Cardiol. 1999; 33(6):1719-23. DOI: 10.1016/s0735-1097(99)00061-3. View

14.

Kojima T, Toda K, Oyanagi T, Yoshiba S, Kobayashi T, Sumitomo N . Early assessment of cardiac troponin I predicts the postoperative cardiac status and clinical course after congenital heart disease surgery. Heart Vessels. 2019; 35(3):417-421. DOI: 10.1007/s00380-019-01497-9. View

15.

Mildh L, Pettila V, Sairanen H, Rautiainen P . Cardiac troponin T levels for risk stratification in pediatric open heart surgery. Ann Thorac Surg. 2006; 82(5):1643-8. DOI: 10.1016/j.athoracsur.2006.05.014. View

16.

Momeni M, Poncelet A, Rubay J, Matta A, Veevaete L, Detaille T . Does Postoperative Cardiac Troponin-I Have Any Prognostic Value in Predicting Midterm Mortality After Congenital Cardiac Surgery?. J Cardiothorac Vasc Anesth. 2016; 31(1):122-127. DOI: 10.1053/j.jvca.2016.02.018. View

17.

Bottio T, Vida V, Padalino M, Gerosa G, Stellin G . Early and long-term prognostic value of Troponin-I after cardiac surgery in newborns and children. Eur J Cardiothorac Surg. 2006; 30(2):250-5. DOI: 10.1016/j.ejcts.2006.05.001. View

18.

Coric D, Smith N . Postoperative troponin measurement as a screening tool for adverse cardiac events in adult patients undergoing moderate or major non-cardiac surgery. Anaesth Intensive Care. 2017; 45(6):683-687. DOI: 10.1177/0310057X1704500606. View

19.

Giannitsis E, Kurz K, Hallermayer K, Jarausch J, Jaffe A, Katus H . Analytical validation of a high-sensitivity cardiac troponin T assay. Clin Chem. 2009; 56(2):254-61. DOI: 10.1373/clinchem.2009.132654. View

20.

Sherwood M, Newby L . High-sensitivity troponin assays: evidence, indications, and reasonable use. J Am Heart Assoc. 2014; 3(1):e000403. PMC: 3959691. DOI: 10.1161/JAHA.113.000403. View